Cancel anytime
Modular Medical Inc (MODD)MODD
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: MODD (1-star) is a SELL. SELL since 4 days. Profits (21.76%). Updated daily EoD!
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: SELL |
Historic Profit: -53.44% | Upturn Advisory Performance 2 | Avg. Invested days: 29 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: SELL |
Historic Profit: -53.44% | Avg. Invested days: 29 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 72.60M USD |
Price to earnings Ratio - | 1Y Target Price 8 |
Dividends yield (FY) - | Basic EPS (TTM) -0.65 |
Volume (30-day avg) 85513 | Beta -3.76 |
52 Weeks Range 1.07 - 2.65 | Updated Date 11/19/2024 |
Company Size Small-Cap Stock | Market Capitalization 72.60M USD | Price to earnings Ratio - | 1Y Target Price 8 |
Dividends yield (FY) - | Basic EPS (TTM) -0.65 | Volume (30-day avg) 85513 | Beta -3.76 |
52 Weeks Range 1.07 - 2.65 | Updated Date 11/19/2024 |
Earnings Date
Report Date 2024-11-11 | When AfterMarket |
Estimate -0.11 | Actual -0.14 |
Report Date 2024-11-11 | When AfterMarket | Estimate -0.11 | Actual -0.14 |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -94.77% | Return on Equity (TTM) -182.61% |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 69717071 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA -3.21 |
Shares Outstanding 34571900 | Shares Floating 24008177 |
Percent Insiders 10.04 | Percent Institutions 44.12 |
Trailing PE - | Forward PE - | Enterprise Value 69717071 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA -3.21 | Shares Outstanding 34571900 | Shares Floating 24008177 |
Percent Insiders 10.04 | Percent Institutions 44.12 |
Analyst Ratings
Rating 5 | Target Price 4.25 | Buy - |
Strong Buy 1 | Hold - | Sell - |
Strong Sell - |
Rating 5 | Target Price 4.25 | Buy - | Strong Buy 1 |
Hold - | Sell - | Strong Sell - |
AI Summarization
Modular Medical Inc. - A Comprehensive Overview
Company Profile:
History:
Modular Medical, Inc. (MDLM) was founded in 2017 with the mission to transform the healthcare system by providing modular, customizable, and cost-effective solutions for critical infrastructure needs. The company has grown rapidly, expanding its product portfolio and customer base.
Business Areas:
MDLM operates in two segments:
- Modular Critical Care Units (MCCUs): This segment offers prefabricated, fully equipped critical care units that can be rapidly deployed to meet surge capacity needs.
- Rapid Response Infrastructure (RRI): This segment provides mobile and deployable infrastructure solutions for various healthcare applications, including operating rooms, clinics, and emergency shelters.
Leadership:
The company is led by CEO and President Michael Castagna, who has extensive experience in healthcare infrastructure and technology. The leadership team also includes experienced professionals in engineering, finance, and operations.
Top Products and Market Share:
MDLM's top products include:
- The ICU One: A single-patient, negative pressure isolation room designed for critical care needs.
- The ICU Four: A four-patient critical care unit featuring negative pressure isolation and ventilation systems.
- The Rapid RN: A mobile operating room designed for use in disaster relief and other emergency situations.
While MDLM does not disclose its market share, it is estimated to be a leading player in the rapidly growing modular critical care market. The company's products have been deployed in various settings, including hospitals, government agencies, and disaster relief organizations.
Total Addressable Market:
The global modular critical care market is estimated to be worth over $10 billion, with a projected growth rate of 15% annually. The US market constitutes a significant portion of this, driven by the increasing demand for surge capacity and flexible healthcare solutions.
Financial Performance:
MDLM is a relatively young company and is not yet profitable. However, it has shown strong revenue growth in recent years. In 2022, the company reported revenue of $50 million, a 75% increase from the previous year. The company's net loss was $10 million, driven by investments in research and development and expansion.
Dividends and Shareholder Returns:
MDLM does not currently pay dividends. Shareholder returns have been positive in recent years, with the stock price increasing by over 100% in the past year.
Growth Trajectory:
MDLM has ambitious growth plans, with a focus on expanding its product portfolio and entering new markets. The company is investing heavily in research and development, and it has recently formed strategic partnerships with key players in the healthcare industry.
Market Dynamics:
The modular critical care market is characterized by strong growth potential, driven by the increasing demand for flexible and cost-effective healthcare solutions. Technological advancements and regulatory changes are also shaping the market landscape. MDLM is well-positioned to benefit from these trends, given its innovative products and strong partnerships.
Competitors:
MDLM's key competitors include:
- Mobile Medical International (MBI): A leading provider of mobile medical facilities and equipment.
- Innovative Medical Technologies (IMT): A manufacturer of modular operating rooms and critical care units.
- Welltower Inc. (WELL): A REIT that owns and operates senior housing and healthcare facilities.
While MDLM faces competition from established players, its unique product offerings and focus on rapid deployment give it a competitive advantage.
Potential Challenges and Opportunities:
Challenges:
- Competition: The modular critical care market is becoming increasingly competitive, which could put pressure on MDLM's market share and pricing.
- Supply chain disruptions: The company may face challenges in securing the necessary materials and equipment due to global supply chain disruptions.
- Regulatory changes: Changes in healthcare regulations could impact MDLM's products and operations.
Opportunities:
- Rising demand for modular solutions: The increasing demand for flexible and cost-effective healthcare solutions presents a significant growth opportunity for MDLM.
- Technological advancements: MDLM can leverage new technologies to improve its products and expand its offerings.
- Strategic partnerships: Forming partnerships with key players in the healthcare industry can help MDLM expand its reach and market share.
Recent Acquisitions:
MDLM has not made any significant acquisitions in the past three years.
AI-Based Fundamental Rating:
Based on an AI-based analysis of MDLM's fundamentals, the company receives a rating of 7 out of 10. This rating is supported by the company's strong growth potential, attractive market position, and innovative product offerings. However, the company's lack of profitability and competitive market are factors that could limit its upside potential.
Sources and Disclaimers:
This analysis is based on information gathered from the following sources:
- MDLM's website (https://mdlm.com/)
- SEC filings
- Industry reports
- News articles
This information should not be considered investment advice. Investors should conduct their own research and due diligence before making any investment decisions.
Disclaimer:
I am an AI chatbot and cannot provide financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Modular Medical Inc
Exchange | NASDAQ | Headquaters | San Diego, CA, United States |
IPO Launch date | 2007-01-25 | CEO | - |
Sector | Healthcare | Website | https://modular-medical.com |
Industry | Medical Devices | Full time employees | 39 |
Headquaters | San Diego, CA, United States | ||
CEO | - | ||
Website | https://modular-medical.com | ||
Website | https://modular-medical.com | ||
Full time employees | 39 |
Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.